Prolactin and autoimmune diseases in humans

Ellie Chuang, Mark E Molitch

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Prolactin has been shown to have immunomodulatory as well as lactogenic effects. Generally less well known is that prolactin may also play a role in the activity of autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. Studies have shown decreasing prolactin production to be beneficial in animal models of autoimmune disease. Thus far, double-blinded, placebo-controlled studies of dopamine agonist treatment in humans with autoimmune disease have been done only in lupus patients, and support the potential efficacy of such agents. Small, open-label trials have also suggested potential benefit in patients with rheumatoid arthritis, Reiter's syndrome, and psoriasis. More studies are required to further delineate the mechanisms by which prolactin affects autoimmune disease activity, to determine in which specific diseases prolactin plays a significant role, and to test the efficacy of prolactin-lowering agents as therapy for such diseases. (www.actabiomedica.it).

Original languageEnglish (US)
Pages (from-to)255-261
Number of pages7
JournalActa Biomedica
Volume78
Issue numberSUPPL. 1
StatePublished - Apr 1 2007

Fingerprint

Prolactin
Autoimmune Diseases
Rheumatoid Arthritis
Reactive Arthritis
Dopamine Agonists
Psoriasis
Systemic Lupus Erythematosus
Animal Models
Placebos
Therapeutics

Keywords

  • Autoimmune disease
  • Hyperprolactinemia
  • Prolactin
  • Rheumatoid arthritis
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chuang, Ellie ; Molitch, Mark E. / Prolactin and autoimmune diseases in humans. In: Acta Biomedica. 2007 ; Vol. 78, No. SUPPL. 1. pp. 255-261.
@article{c1f28d60bcec4716874dc7787009be69,
title = "Prolactin and autoimmune diseases in humans",
abstract = "Prolactin has been shown to have immunomodulatory as well as lactogenic effects. Generally less well known is that prolactin may also play a role in the activity of autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. Studies have shown decreasing prolactin production to be beneficial in animal models of autoimmune disease. Thus far, double-blinded, placebo-controlled studies of dopamine agonist treatment in humans with autoimmune disease have been done only in lupus patients, and support the potential efficacy of such agents. Small, open-label trials have also suggested potential benefit in patients with rheumatoid arthritis, Reiter's syndrome, and psoriasis. More studies are required to further delineate the mechanisms by which prolactin affects autoimmune disease activity, to determine in which specific diseases prolactin plays a significant role, and to test the efficacy of prolactin-lowering agents as therapy for such diseases. (www.actabiomedica.it).",
keywords = "Autoimmune disease, Hyperprolactinemia, Prolactin, Rheumatoid arthritis, Systemic lupus erythematosus",
author = "Ellie Chuang and Molitch, {Mark E}",
year = "2007",
month = "4",
day = "1",
language = "English (US)",
volume = "78",
pages = "255--261",
journal = "Acta Biomedica de l'Ateneo Parmense",
issn = "0392-4203",
publisher = "L'Ateneo Parmense",
number = "SUPPL. 1",

}

Chuang, E & Molitch, ME 2007, 'Prolactin and autoimmune diseases in humans', Acta Biomedica, vol. 78, no. SUPPL. 1, pp. 255-261.

Prolactin and autoimmune diseases in humans. / Chuang, Ellie; Molitch, Mark E.

In: Acta Biomedica, Vol. 78, No. SUPPL. 1, 01.04.2007, p. 255-261.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prolactin and autoimmune diseases in humans

AU - Chuang, Ellie

AU - Molitch, Mark E

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Prolactin has been shown to have immunomodulatory as well as lactogenic effects. Generally less well known is that prolactin may also play a role in the activity of autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. Studies have shown decreasing prolactin production to be beneficial in animal models of autoimmune disease. Thus far, double-blinded, placebo-controlled studies of dopamine agonist treatment in humans with autoimmune disease have been done only in lupus patients, and support the potential efficacy of such agents. Small, open-label trials have also suggested potential benefit in patients with rheumatoid arthritis, Reiter's syndrome, and psoriasis. More studies are required to further delineate the mechanisms by which prolactin affects autoimmune disease activity, to determine in which specific diseases prolactin plays a significant role, and to test the efficacy of prolactin-lowering agents as therapy for such diseases. (www.actabiomedica.it).

AB - Prolactin has been shown to have immunomodulatory as well as lactogenic effects. Generally less well known is that prolactin may also play a role in the activity of autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. Studies have shown decreasing prolactin production to be beneficial in animal models of autoimmune disease. Thus far, double-blinded, placebo-controlled studies of dopamine agonist treatment in humans with autoimmune disease have been done only in lupus patients, and support the potential efficacy of such agents. Small, open-label trials have also suggested potential benefit in patients with rheumatoid arthritis, Reiter's syndrome, and psoriasis. More studies are required to further delineate the mechanisms by which prolactin affects autoimmune disease activity, to determine in which specific diseases prolactin plays a significant role, and to test the efficacy of prolactin-lowering agents as therapy for such diseases. (www.actabiomedica.it).

KW - Autoimmune disease

KW - Hyperprolactinemia

KW - Prolactin

KW - Rheumatoid arthritis

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=34347267278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347267278&partnerID=8YFLogxK

M3 - Article

VL - 78

SP - 255

EP - 261

JO - Acta Biomedica de l'Ateneo Parmense

JF - Acta Biomedica de l'Ateneo Parmense

SN - 0392-4203

IS - SUPPL. 1

ER -

Chuang E, Molitch ME. Prolactin and autoimmune diseases in humans. Acta Biomedica. 2007 Apr 1;78(SUPPL. 1):255-261.